vs
Petco Health & Wellness Company, Inc.（WOOF）与West Pharmaceutical Services（WST）财务数据对比。点击上方公司名可切换其他公司
Petco Health & Wellness Company, Inc.的季度营收约是West Pharmaceutical Services的1.8倍（$1.5B vs $805.0M），West Pharmaceutical Services净利率更高（16.4% vs 0.6%，领先15.8%），West Pharmaceutical Services同比增速更快（7.5% vs -3.1%），West Pharmaceutical Services自由现金流更多（$175.0M vs $60.6M），过去两年West Pharmaceutical Services的营收复合增速更高（7.6% vs -6.5%）
Petco健康与 wellness公司是美国知名宠物零售商，总部分别设于圣迭戈与圣安东尼奥。公司主营宠物食品、宠物用品及相关宠物服务，同时也售卖部分品类的活宠小型宠物，是北美宠物零售领域的老牌企业。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商，1923年成立，总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件，曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
WOOF vs WST — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $805.0M |
| 净利润 | $9.3M | $132.1M |
| 毛利率 | 38.9% | 37.8% |
| 营业利润率 | 2.0% | 19.5% |
| 净利率 | 0.6% | 16.4% |
| 营收同比 | -3.1% | 7.5% |
| 净利润同比 | 156.0% | 1.5% |
| 每股收益（稀释后） | $0.03 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.5B | $805.0M | ||
| Q3 25 | $1.5B | $804.6M | ||
| Q2 25 | $1.5B | $766.5M | ||
| Q1 25 | $1.6B | $698.0M | ||
| Q4 24 | $1.5B | $748.8M | ||
| Q3 24 | $1.5B | $746.9M | ||
| Q2 24 | $1.5B | $702.1M | ||
| Q1 24 | $1.7B | $695.4M |
| Q4 25 | $9.3M | $132.1M | ||
| Q3 25 | $14.0M | $140.0M | ||
| Q2 25 | $-11.7M | $131.8M | ||
| Q1 25 | $-13.8M | $89.8M | ||
| Q4 24 | $-16.7M | $130.1M | ||
| Q3 24 | $-24.8M | $136.0M | ||
| Q2 24 | $-46.5M | $111.3M | ||
| Q1 24 | $-22.6M | $115.3M |
| Q4 25 | 38.9% | 37.8% | ||
| Q3 25 | 39.3% | 36.6% | ||
| Q2 25 | 38.2% | 35.7% | ||
| Q1 25 | 38.0% | 33.2% | ||
| Q4 24 | 38.1% | 36.5% | ||
| Q3 24 | 38.1% | 35.4% | ||
| Q2 24 | 37.8% | 32.8% | ||
| Q1 24 | 36.2% | 33.1% |
| Q4 25 | 2.0% | 19.5% | ||
| Q3 25 | 2.9% | 20.8% | ||
| Q2 25 | 1.1% | 20.1% | ||
| Q1 25 | 1.1% | 15.3% | ||
| Q4 24 | 0.3% | 21.3% | ||
| Q3 24 | 0.2% | 21.6% | ||
| Q2 24 | -1.1% | 18.0% | ||
| Q1 24 | 0.0% | 17.7% |
| Q4 25 | 0.6% | 16.4% | ||
| Q3 25 | 0.9% | 17.4% | ||
| Q2 25 | -0.8% | 17.2% | ||
| Q1 25 | -0.9% | 12.9% | ||
| Q4 24 | -1.1% | 17.4% | ||
| Q3 24 | -1.6% | 18.2% | ||
| Q2 24 | -3.0% | 15.9% | ||
| Q1 24 | -1.3% | 16.6% |
| Q4 25 | $0.03 | $1.82 | ||
| Q3 25 | $0.05 | $1.92 | ||
| Q2 25 | $-0.04 | $1.82 | ||
| Q1 25 | $-0.05 | $1.23 | ||
| Q4 24 | $-0.06 | $1.78 | ||
| Q3 24 | $-0.09 | $1.85 | ||
| Q2 24 | $-0.17 | $1.51 | ||
| Q1 24 | $-0.09 | $1.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $237.4M | $791.3M |
| 总债务越低越好 | — | $202.8M |
| 股东权益账面价值 | $1.2B | $3.2B |
| 总资产 | $5.2B | $4.3B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
| Q4 25 | $237.4M | $791.3M | ||
| Q3 25 | $188.7M | $628.5M | ||
| Q2 25 | $133.3M | $509.7M | ||
| Q1 25 | $165.8M | $404.2M | ||
| Q4 24 | $116.7M | $484.6M | ||
| Q3 24 | $127.6M | $490.9M | ||
| Q2 24 | $89.7M | $446.2M | ||
| Q1 24 | $125.4M | $601.8M |
| Q4 25 | — | $202.8M | ||
| Q3 25 | — | $202.7M | ||
| Q2 25 | — | $202.6M | ||
| Q1 25 | — | $202.6M | ||
| Q4 24 | — | $202.6M | ||
| Q3 24 | — | $202.6M | ||
| Q2 24 | — | $205.8M | ||
| Q1 24 | — | $206.2M |
| Q4 25 | $1.2B | $3.2B | ||
| Q3 25 | $1.1B | $3.1B | ||
| Q2 25 | $1.1B | $2.9B | ||
| Q1 25 | $1.1B | $2.7B | ||
| Q4 24 | $1.1B | $2.7B | ||
| Q3 24 | $1.1B | $2.8B | ||
| Q2 24 | $1.2B | $2.6B | ||
| Q1 24 | $1.2B | $2.7B |
| Q4 25 | $5.2B | $4.3B | ||
| Q3 25 | $5.2B | $4.1B | ||
| Q2 25 | $5.1B | $4.0B | ||
| Q1 25 | $5.2B | $3.6B | ||
| Q4 24 | $5.2B | $3.6B | ||
| Q3 24 | $5.3B | $3.7B | ||
| Q2 24 | $5.3B | $3.5B | ||
| Q1 24 | $5.4B | $3.6B |
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.08× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $90.1M | $251.1M |
| 自由现金流经营现金流 - 资本支出 | $60.6M | $175.0M |
| 自由现金流率自由现金流/营收 | 4.1% | 21.7% |
| 资本支出强度资本支出/营收 | 2.0% | 9.5% |
| 现金转化率经营现金流/净利润 | 9.66× | 1.90× |
| 过去12个月自由现金流最近4个季度 | $129.6M | $468.9M |
8季度趋势，按日历期对齐
| Q4 25 | $90.1M | $251.1M | ||
| Q3 25 | $85.9M | $197.2M | ||
| Q2 25 | $-15.5M | $177.1M | ||
| Q1 25 | $96.0M | $129.4M | ||
| Q4 24 | $20.7M | $190.1M | ||
| Q3 24 | $69.4M | $180.1M | ||
| Q2 24 | $-8.4M | $165.0M | ||
| Q1 24 | $47.0M | $118.2M |
| Q4 25 | $60.6M | $175.0M | ||
| Q3 25 | $53.8M | $133.9M | ||
| Q2 25 | $-43.9M | $101.9M | ||
| Q1 25 | $59.0M | $58.1M | ||
| Q4 24 | $-10.3M | $85.2M | ||
| Q3 24 | $42.0M | $98.8M | ||
| Q2 24 | $-41.1M | $64.8M | ||
| Q1 24 | $-2.0M | $27.6M |
| Q4 25 | 4.1% | 21.7% | ||
| Q3 25 | 3.6% | 16.6% | ||
| Q2 25 | -2.9% | 13.3% | ||
| Q1 25 | 3.8% | 8.3% | ||
| Q4 24 | -0.7% | 11.4% | ||
| Q3 24 | 2.8% | 13.2% | ||
| Q2 24 | -2.7% | 9.2% | ||
| Q1 24 | -0.1% | 4.0% |
| Q4 25 | 2.0% | 9.5% | ||
| Q3 25 | 2.2% | 7.9% | ||
| Q2 25 | 1.9% | 9.8% | ||
| Q1 25 | 2.4% | 10.2% | ||
| Q4 24 | 2.1% | 14.0% | ||
| Q3 24 | 1.8% | 10.9% | ||
| Q2 24 | 2.1% | 14.3% | ||
| Q1 24 | 2.9% | 13.0% |
| Q4 25 | 9.66× | 1.90× | ||
| Q3 25 | 6.15× | 1.41× | ||
| Q2 25 | — | 1.34× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | 1.46× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.48× | ||
| Q1 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
WOOF
| Consumables | $731.5M | 50% |
| Supplies And Companion Animals | $478.1M | 33% |
| Services & Other | $254.8M | 17% |
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
